16-amino-7-oxa-1,8,11,18-tetrazapentacyclo[17.2.2.212,15.16,9.03,5]hexacosa-6(26),8,12(25),13,15(24)-pentaene-10,17-dione;5-cyclopropyl-N-[[3-[(6-methyl-3-pyridinyl)carbamoyl]phenyl]-piperidin-4-ylmethyl]-1,2-oxazole-3-carboxamide
C47H54N10O6 — CID 145039797
Data last refreshed: (MolForge compound catalog, from PubChem)
About 16-amino-7-oxa-1,8,11,18-tetrazapentacyclo[17.2.2.212,15.16,9.03,5]hexacosa-6(26),8,12(25),13,15(24)-pentaene-10,17-dione;5-cyclopropyl-N-[[3-[(6-methyl-3-pyridinyl)carbamoyl]phenyl]-piperidin-4-ylmethyl]-1,2-oxazole-3-carboxamide
16-amino-7-oxa-1,8,11,18-tetrazapentacyclo[17.2.2.212,15.16,9.03,5]hexacosa-6(26),8,12(25),13,15(24)-pentaene-10,17-dione;5-cyclopropyl-N-[[3-[(6-methyl-3-pyridinyl)carbamoyl]phenyl]-piperidin-4-ylmethyl]-1,2-oxazole-3-carboxamide (PubChem CID 145039797) has the molecular formula C47H54N10O6 and a molecular weight of 855.01 g/mol. Its IUPAC name is 16-amino-7-oxa-1,8,11,18-tetrazapentacyclo[17.2.2.212,15.16,9.03,5]hexacosa-6(26),8,12(25),13,15(24)-pentaene-10,17-dione;5-cyclopropyl-N-[[3-[(6-methyl-3-pyridinyl)carbamoyl]phenyl]-piperidin-4-ylmethyl]-1,2-oxazole-3-carboxamide.
Molecular Properties
| Compound Name | 16-amino-7-oxa-1,8,11,18-tetrazapentacyclo[17.2.2.212,15.16,9.03,5]hexacosa-6(26),8,12(25),13,15(24)-pentaene-10,17-dione;5-cyclopropyl-N-[[3-[(6-methyl-3-pyridinyl)carbamoyl]phenyl]-piperidin-4-ylmethyl]-1,2-oxazole-3-carboxamide |
|---|---|
| PubChem CID | 145039797 |
| Molecular Formula | C47H54N10O6 |
| Molecular Weight | 855.01 g/mol |
| Exact Mass | 854.42 |
| IUPAC Name | 16-amino-7-oxa-1,8,11,18-tetrazapentacyclo[17.2.2.212,15.16,9.03,5]hexacosa-6(26),8,12(25),13,15(24)-pentaene-10,17-dione;5-cyclopropyl-N-[[3-[(6-methyl-3-pyridinyl)carbamoyl]phenyl]-piperidin-4-ylmethyl]-1,2-oxazole-3-carboxamide |
| SMILES | Cc1ccc(NC(=O)c2cccc(C(NC(=O)c3cc(C4CC4)on3)C3CCNCC3)c2)cn1.NC1C(=O)NC2CCN(CC2)CC2CC2c2cc(no2)C(=O)Nc2ccc1cc2 |
| InChI | InChI=1S/C26H29N5O3.C21H25N5O3/c1-16-5-8-21(15-28-16)29-25(32)20-4-2-3-19(13-20)24(18-9-11-27-12-10-18)30-26(33)22-14-23(34-31-22)17-6-7-17;22-19-12-1-3-14(4-2-12)23-20(27)17-10-18(29-25-17)16-9-13(16)11-26-7-5-15(6-8-26)24-21(19)28/h2-5,8,13-15,17-18,24,27H,6-7,9-12H2,1H3,(H,29,32)(H,30,33);1-4,10,13,15-16,19H,5-9,11,22H2,(H,23,27)(H,24,28) |
| InChIKey | HTIZHUSKXNSGHW-UHFFFAOYSA-N |
| XLogP | 5.60 |
| TPSA | 222.64 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 63 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 855.01 |
| LogP ≤ 5 | 5.60 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 145039797 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.